Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis Patients

Svenja Kiljan, Marloes Prins, Bart M. Baselmans, John G.J.M. Bol, Geert J. Schenk, Anne Marie van Dam

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Cognitive dysfunction occurs frequently in multiple sclerosis (MS). Research suggests that hippocampal lesions and GABAergic neurotransmitter changes contribute to cognitive dysfunction. In the present study, we aim to determine the cellular changes in GABAergic expression in MS hippocampus related to inflammation and demyelination. To this end, the presence and inflammatory activity of demyelinating lesions was determined by immunohistochemistry in human postmortem hippocampal tissue of 15 MS patients and 9 control subjects. Subsequently, GABAergic cells were visualized using parvalbumin (PV) and glutamate acid decarboxylase 67 (GAD67) markers. Fluorescent colabeling was performed of GAD67 with neuronal nuclei, PV, astrocytic glial fibrillary acidic protein, or vesicular GABA transporter. We observed increased GAD67-positive (GAD67+) neuron and synapse numbers in the CA1 of MS patients with active hippocampal lesions, not due to neurogenesis. The number and size of PV-positive neurons remained unchanged. GAD67+ astrocytes were more numerous in hippocampal white matter than grey matter lesions. Additionally, in MS patients with active hippocampal lesions GAD67+ astrocyte surface area was increased. Disturbed cognition was most prevalent in MS patients with active hippocampal lesions. Summarizing, increased GAD67 immunoreactivity occurs in neurons and astrocytes and relates to hippocampal inflammation and possibly disturbed cognition in MS.

Original languageEnglish
Pages (from-to)480-491
Number of pages12
JournalJournal of neuropathology and experimental neurology
Volume78
Issue number6
DOIs
Publication statusPublished - 1 Jun 2019

Fingerprint

Glutamate Decarboxylase
Astrocytes
Multiple Sclerosis
Neurons
Acids
Parvalbumins
Cognition
Inflammation
Glial Fibrillary Acidic Protein
Neurogenesis
Demyelinating Diseases
Synapses
Neurotransmitter Agents
Hippocampus
Immunohistochemistry
Research

Keywords

  • Astrocyte
  • GABA
  • Glutamate acid decarboxylase
  • Hippocampus
  • Interneuron
  • Multiple sclerosis
  • Parvalbumin

Cite this

Kiljan, Svenja ; Prins, Marloes ; Baselmans, Bart M. ; Bol, John G.J.M. ; Schenk, Geert J. ; van Dam, Anne Marie. / Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis Patients. In: Journal of neuropathology and experimental neurology. 2019 ; Vol. 78, No. 6. pp. 480-491.
@article{d44baab54c2640feacbc499416097ffd,
title = "Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis Patients",
abstract = "Cognitive dysfunction occurs frequently in multiple sclerosis (MS). Research suggests that hippocampal lesions and GABAergic neurotransmitter changes contribute to cognitive dysfunction. In the present study, we aim to determine the cellular changes in GABAergic expression in MS hippocampus related to inflammation and demyelination. To this end, the presence and inflammatory activity of demyelinating lesions was determined by immunohistochemistry in human postmortem hippocampal tissue of 15 MS patients and 9 control subjects. Subsequently, GABAergic cells were visualized using parvalbumin (PV) and glutamate acid decarboxylase 67 (GAD67) markers. Fluorescent colabeling was performed of GAD67 with neuronal nuclei, PV, astrocytic glial fibrillary acidic protein, or vesicular GABA transporter. We observed increased GAD67-positive (GAD67+) neuron and synapse numbers in the CA1 of MS patients with active hippocampal lesions, not due to neurogenesis. The number and size of PV-positive neurons remained unchanged. GAD67+ astrocytes were more numerous in hippocampal white matter than grey matter lesions. Additionally, in MS patients with active hippocampal lesions GAD67+ astrocyte surface area was increased. Disturbed cognition was most prevalent in MS patients with active hippocampal lesions. Summarizing, increased GAD67 immunoreactivity occurs in neurons and astrocytes and relates to hippocampal inflammation and possibly disturbed cognition in MS.",
keywords = "Astrocyte, GABA, Glutamate acid decarboxylase, Hippocampus, Interneuron, Multiple sclerosis, Parvalbumin",
author = "Svenja Kiljan and Marloes Prins and Baselmans, {Bart M.} and Bol, {John G.J.M.} and Schenk, {Geert J.} and {van Dam}, {Anne Marie}",
year = "2019",
month = "6",
day = "1",
doi = "10.1093/jnen/nlz028",
language = "English",
volume = "78",
pages = "480--491",
journal = "Journal of neuropathology and experimental neurology",
issn = "1554-6578",
publisher = "Oxford University press",
number = "6",

}

Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis Patients. / Kiljan, Svenja; Prins, Marloes; Baselmans, Bart M.; Bol, John G.J.M.; Schenk, Geert J.; van Dam, Anne Marie.

In: Journal of neuropathology and experimental neurology, Vol. 78, No. 6, 01.06.2019, p. 480-491.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis Patients

AU - Kiljan, Svenja

AU - Prins, Marloes

AU - Baselmans, Bart M.

AU - Bol, John G.J.M.

AU - Schenk, Geert J.

AU - van Dam, Anne Marie

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Cognitive dysfunction occurs frequently in multiple sclerosis (MS). Research suggests that hippocampal lesions and GABAergic neurotransmitter changes contribute to cognitive dysfunction. In the present study, we aim to determine the cellular changes in GABAergic expression in MS hippocampus related to inflammation and demyelination. To this end, the presence and inflammatory activity of demyelinating lesions was determined by immunohistochemistry in human postmortem hippocampal tissue of 15 MS patients and 9 control subjects. Subsequently, GABAergic cells were visualized using parvalbumin (PV) and glutamate acid decarboxylase 67 (GAD67) markers. Fluorescent colabeling was performed of GAD67 with neuronal nuclei, PV, astrocytic glial fibrillary acidic protein, or vesicular GABA transporter. We observed increased GAD67-positive (GAD67+) neuron and synapse numbers in the CA1 of MS patients with active hippocampal lesions, not due to neurogenesis. The number and size of PV-positive neurons remained unchanged. GAD67+ astrocytes were more numerous in hippocampal white matter than grey matter lesions. Additionally, in MS patients with active hippocampal lesions GAD67+ astrocyte surface area was increased. Disturbed cognition was most prevalent in MS patients with active hippocampal lesions. Summarizing, increased GAD67 immunoreactivity occurs in neurons and astrocytes and relates to hippocampal inflammation and possibly disturbed cognition in MS.

AB - Cognitive dysfunction occurs frequently in multiple sclerosis (MS). Research suggests that hippocampal lesions and GABAergic neurotransmitter changes contribute to cognitive dysfunction. In the present study, we aim to determine the cellular changes in GABAergic expression in MS hippocampus related to inflammation and demyelination. To this end, the presence and inflammatory activity of demyelinating lesions was determined by immunohistochemistry in human postmortem hippocampal tissue of 15 MS patients and 9 control subjects. Subsequently, GABAergic cells were visualized using parvalbumin (PV) and glutamate acid decarboxylase 67 (GAD67) markers. Fluorescent colabeling was performed of GAD67 with neuronal nuclei, PV, astrocytic glial fibrillary acidic protein, or vesicular GABA transporter. We observed increased GAD67-positive (GAD67+) neuron and synapse numbers in the CA1 of MS patients with active hippocampal lesions, not due to neurogenesis. The number and size of PV-positive neurons remained unchanged. GAD67+ astrocytes were more numerous in hippocampal white matter than grey matter lesions. Additionally, in MS patients with active hippocampal lesions GAD67+ astrocyte surface area was increased. Disturbed cognition was most prevalent in MS patients with active hippocampal lesions. Summarizing, increased GAD67 immunoreactivity occurs in neurons and astrocytes and relates to hippocampal inflammation and possibly disturbed cognition in MS.

KW - Astrocyte

KW - GABA

KW - Glutamate acid decarboxylase

KW - Hippocampus

KW - Interneuron

KW - Multiple sclerosis

KW - Parvalbumin

UR - http://www.scopus.com/inward/record.url?scp=85066251347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066251347&partnerID=8YFLogxK

U2 - 10.1093/jnen/nlz028

DO - 10.1093/jnen/nlz028

M3 - Article

VL - 78

SP - 480

EP - 491

JO - Journal of neuropathology and experimental neurology

JF - Journal of neuropathology and experimental neurology

SN - 1554-6578

IS - 6

ER -